IMOVAX POLIO

Product Overview

About IMOVAX POLIO

IMOVAX POLIO is a vaccine designed to protect against poliomyelitis, a highly infectious disease caused by the poliovirus. The vaccine contains inactivated strains of the poliovirus, specifically POLIOVIRUS TYPE 2 MEF1 (INACTIVATED), POLIOVIRUS TYPE 3 SAUKETT (INACTIVATED), and POLIOVIRUS TYPE 1 MAHONEY (INACTIVATED). These inactivated viruses stimulate the body's immune system to produce antibodies that can recognize and neutralize the live poliovirus, thereby preventing the development of the disease.

Key Benefits & Uses

• Prevention of poliomyelitis, a highly infectious disease that can cause paralysis and other serious health complications.
• Protection against all three serotypes of the poliovirus (Types 1, 2, and 3).
• Indicated for use in individuals who have not previously been vaccinated against poliomyelitis or who have not completed the recommended vaccination series.

Active Ingredient & Action

The inactivated poliovirus strains in IMOVAX POLIO work by stimulating the body's immune system to produce antibodies that can recognize and neutralize the live poliovirus. This immune response helps to prevent the development of poliomyelitis and provides long-term protection against the disease.

Important Notes

IMOVAX POLIO should be administered according to the recommended vaccination schedule and guidelines. It is essential to follow the instructions provided by the healthcare provider or the vaccine manufacturer. Individuals with a history of severe allergic reactions to previous doses of the vaccine or its components should not receive IMOVAX POLIO. As with any vaccine, IMOVAX POLIO may cause side effects, such as redness, swelling, or pain at the injection site, or systemic reactions like fever or fatigue. If you experience any unusual or severe side effects, consult your healthcare provider promptly.